Overview

Science-Led Innovation. Global Impact.

Biocon Biologics is driving science-led disruption to make affordable, life-changing medicines accessible to everyone — powered by deep expertise, skilled talent, and cutting-edge innovation.

Our unique lab-to-patient model enables us to develop, manufacture and commercialize biosimilars — including insulins, monoclonal antibodies (mAbs) and recombinant proteins — across oncology, immunology, diabetes, ophthalmology and bone health.

With over 20 years of innovation and US$1 billion invested in advanced technologies, we’ve built one of the world’s most comprehensive biosimilar pipelines.

Our research centers in Bengaluru and Chennai unite multidisciplinary teams in molecular biology, bioengineering, analytical sciences, clinical development, regulatory science, and intellectual property — accelerating access to high-quality biologics worldwide.

Our scientific legacy shines through Biocon Academy, which has spent a decade shaping industry-ready talent — training over 1,200 students and fueling a future-ready life sciences workforce.

Our Global Scale Capabilities

What does it take to transform the lives of millions of patients worldwide? Commitment to Quality and Global Scale. Watch here how Biocon Biologics is pursuing its journey of transforming #healthcare, transforming lives.
Related Links

Manufacturing

We have built global scale and world-class capabilities that leverage advanced technologies and an unwavering commitment to quality, to transform...
Read More

Research & Development

Our ability to develop and commercialize high-quality biosimilar insulins, monoclonal antibodies and conjugated recombinant proteins is driving a transformative shift...
Read More

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics EU Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics Corporate Website

You are now leaving the Biocon Biologics Corporate website for a Biocon Biologics U.S. Corporate microsite that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree

Leaving the Biocon Biologics site

You are now leaving the Biocon Biologics page for a Biocon Biologics affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon Biologics affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree